ZoeNCure Therapeutics Secures INR 20 Crore Seed Investment to Accelerate Next-Generation Antibody Drug Conjugate (ADC) Program
Business Wire India ZoeNCure Therapeutics Pvt. Ltd., an oncology biotechnology company focused on developing high-potency targeted cancer therapies, today announced…